2019 BioHealth Capital Region Forum

Top 3 by 2023

Miss the 2019 BioHealth Capital Region Forum?


20% of the top influencers worldwide in vaccine development


World-class tech + big data + biotech + White House Precision Medicine Initiative = new frontiers in patient-centered medicine


MD | DC | VA

Our Goal: To become a Top 3 BioHealth Hub by 2023.

We are the research engine for the nation and the world. A lifeblood of support for taking new medicines to market. A place where health policymakers and patient advocates seek a better way forward. A home to the established and the startup, pioneering big ideas for human health and hope.

Driving Innovation and Entrepreneurship

  • World–renowned research institutions and universities
  • Influential policymakers and advocacy groups pioneering new health strategies
  • World–leading infectious disease research and vaccine development
  • Fastest growing region for healthcare companies in the U.S.
  • Rated #1 in the nation for science and engineering talent
  • Mission control for the National Cancer Moonshot Initiative

Founding Partners

Maryland VC totals ‘rebound’ with $226M raised in Q2

July 16, 2019

Venture funding raised by Maryland companies took a big jump in the second quarter of the year, as companies in the state raised a total of $226 million. That’s a…

Illumina Establishes First East Coast Location in University of Maryland BioPark

July 11, 2019

BALTIMORE, July 11, 2019 /PRNewswire/ — The University of Maryland (UM) BioPark and Wexford Science & Technology, LLC, today announced Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems,…

MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China

July 10, 2019

ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), a China and U.S.-based clinical-stage…

WBJ – Altimmune to acquire California company for up to $93M

July 9, 2019

Maryland biotech Altimmune Inc. has reached an agreement to acquire California drug developer Spitfire Pharma Inc. in a move that sent the local company’s stock skyrocketing Tuesday. Under the deal,…

Novavax Signs Strategic Partnership with Catalent’s Paragon BioServices, Secures Company Future and 100’s of Jobs

June 27, 2019

Montgomery County Maryland’s Novavax has had a rocky road to say the least, and the latest failed Phase III RSV trial earlier this year put the company in a difficult…

NanoCellect® and QIAGEN streamline single-cell RNA-Seq by sorting directly into RNAseq-ready plates

June 24, 2019

A non-exclusive collaboration between NanoCellect and QIAGEN aims to accelerate adoption and ease of use of single-cell RNAseq by combining the power of NanoCellect’s WOLF® Cell Sorter with QIAGEN’s QIAseq®…